Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoring

  • Monica Gandhi
  • , David V. Glidden
  • , Albert Liu
  • , Peter L. Anderson
  • , Howard Horng
  • , Patricia Defechereux
  • , Juan V. Guanira
  • , Beatriz Grinsztejn
  • , Suwat Chariyalertsak
  • , Linda Gail Bekker
  • , Robert M. Grant
  • University of California San Francisco
  • San Francisco Department of Public Health
  • University of Colorado Denver
  • University of California San Francisco Center for Tuberculosis
  • Gladstone Institutes
  • Investigaciones Medicas en Salud
  • Instituto Nacional de Infectologia Evandro Chagas (INI)
  • Chiang Mai University
  • University of Cape Town

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

70 Citas (Scopus)

Resumen

Self-reported adherence to pre-exposure prophylaxis (PrEP) has limitations, raising interest in pharmacologic monitoring. Drug concentrations in hair and dried blood spots (DBS) are used to assess long-term-exposure; hair shipment/storage occurs at room temperature. The iPrEx Open Label Extension collected DBS routinely, with opt-in hair collection; concentrations were measured with liquid chromatography/tandem mass spectrometry. In 806 hair-DBS pairs, tenofovir (TFV) hair levels and TFV diphosphate (DP) in DBS were strongly correlated (Spearman coefficient r = 0.734; P <. 001), as were hair TFV/DBS emtricitabine (FTC) triphosphate (TP) (r = 0.781; P <. 001); hair FTC/DBS TFV-DP (r = 0.74; P <. 001); hair FTC/DBS FTC-TP (r = 0.587; P <. 001). Drug detectability was generally concordant by matrix. Hair TFV/FTC concentrations correlate strongly with DBS levels, which are predictive of PrEP outcomes.

Idioma originalInglés
Páginas (desde-hasta)1402-1406
Número de páginas5
PublicaciónJournal of Infectious Diseases
Volumen212
N.º9
DOI
EstadoPublicada - 1 nov. 2015
Publicado de forma externa

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar
  2. ODS 5: Igualdad de género
    ODS 5: Igualdad de género

Huella

Profundice en los temas de investigación de 'Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoring'. En conjunto forman una huella única.

Citar esto